Solstice Advanced Materials canceled its acquisition of Element Solutions due to shareholder concerns, amidst mixed M&A sentiment in the chemical sector including the Olin-Huntsman merger. The FDA als
Solstice Advanced Materials and Element Solutions mutually terminated their $14.5 billion acquisition after shareholder feedback. Both firms will operate independently despite the deal's aim to boost
Solstice Advanced Materials and Element Solutions announced the termination of their $14.5 billion merger deal, deciding to remain independent companies. The transaction aimed to combine their capabil
Solstice Advanced Materials and Element Solutions mutually terminated their $14.5 billion merger following shareholder feedback favoring independence. The proposed combination aimed to create a leadin
ChemBrief